Long-term Extension of GTX-102 in Angelman Syndrome
NCT06415344
·
clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
255
Enrollment
INDUSTRY
Sponsor class
Conditions
Angelman Syndrome
Interventions
DRUG:
GTX-102
Sponsor
Ultragenyx Pharmaceutical Inc